{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:32:15Z","timestamp":1773495135443,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82422024"],"award-info":[{"award-number":["82422024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Fund for Outstanding Young Scholars","award":["JQ22020"],"award-info":[{"award-number":["JQ22020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40263-026-01271-2","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:33:25Z","timestamp":1770028405000},"page":"497-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Early Antithrombotic Therapy Within 24\u202fHours of Intravenous Thrombolysis in Acute Ischemic Stroke"],"prefix":"10.1007","volume":"40","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"12","key":"1271_CR1","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"2","key":"1271_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/bc.bc_70_22","volume":"9","author":"N Yang","year":"2023","unstructured":"Yang N, Lee H, Wu C. Intravenous thrombolysis for acute ischemic stroke: from alteplase to tenecteplase. Brain Circ. 2023;9(2):61\u20133.","journal-title":"Brain Circ"},{"issue":"6","key":"1271_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/WNL.59.6.862","volume":"59","author":"AV Alexandrov","year":"2002","unstructured":"Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59(6):862\u20137.","journal-title":"Neurology"},{"issue":"7","key":"1271_CR4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/01.STR.0000170711.43405.81","volume":"36","author":"M Rubiera","year":"2005","unstructured":"Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36(7):1452\u20136.","journal-title":"Stroke"},{"issue":"4","key":"1271_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4103\/bc.bc_37_23","volume":"9","author":"Y Kan","year":"2023","unstructured":"Kan Y, Li S, Zhang B, Ding Y, Zhao W, Ji X. No-reflow phenomenon following stroke recanalization therapy: clinical assessment advances: a narrative review. Brain Circ. 2023;9(4):214\u201321.","journal-title":"Brain Circ"},{"issue":"4","key":"1271_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4103\/bc.bc_46_24","volume":"10","author":"ES Gencer","year":"2024","unstructured":"Gencer ES, Yilmaz E, Arsava EM, Gocmen R, Topcuoglu MA. Cerebral arterial collateral status, but not venous outflow profiles, modifies the effect of intravenous tissue plasminogen activator in acute ischemic stroke. Brain Circ. 2024;10(4):336\u201342.","journal-title":"Brain Circ"},{"issue":"10","key":"1271_CR7","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1161\/01.STR.30.10.2101","volume":"30","author":"K Fassbender","year":"1999","unstructured":"Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, et al. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke. 1999;30(10):2101\u20134.","journal-title":"Stroke"},{"issue":"7","key":"1271_CR8","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1161\/01.STR.0000226897.43749.27","volume":"37","author":"D Tanne","year":"2006","unstructured":"Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR, Group NrSS. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke. 2006;37(7):1798\u2013804.","journal-title":"Stroke"},{"issue":"24","key":"1271_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological D, Stroke rt PASSG","year":"1995","unstructured":"National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"1271_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/bc.bc_159_24","volume":"10","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Fayyaz AI, Ding Y, Ji X, Zhao W. Recent advances in the prevention of secondary ischemic stroke: a narrative review. Brain Circ. 2024;10(4):283\u201395.","journal-title":"Brain Circ"},{"issue":"5","key":"1271_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003242","volume":"5","author":"S Luo","year":"2016","unstructured":"Luo S, Zhuang M, Zeng W, Tao J. Intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy: a systematic review and meta\u2010analysis of 19 studies. J Am Heart Assoc. 2016;5(5):e003242.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1271_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/ijs.12431","volume":"10","author":"X Pan","year":"2015","unstructured":"Pan X, Zhu Y, Zheng D, Liu Y, Yu F, Yang J. Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials. Int J Stroke. 2015;10(3):317\u201323.","journal-title":"Int J Stroke"},{"key":"1271_CR13","doi-asserted-by":"crossref","unstructured":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group. Lancet. 1995;346(8989):1509-14.","DOI":"10.1016\/S0140-6736(95)92049-8"},{"issue":"9843","key":"1271_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","volume":"380","author":"SM Zinkstok","year":"2012","unstructured":"Zinkstok SM, Roos YB, Investigators A. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet. 2012;380(9843):731\u20137.","journal-title":"Lancet"},{"issue":"3","key":"1271_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/bc.bc_15_24","volume":"10","author":"M Toudou-Daouda","year":"2024","unstructured":"Toudou-Daouda M, Yatwa-Zaniwe RV, Aminou-Tassiou NR, Baby M, Soumah D, Altarcha T, et al. Intravenous thrombolysis plus tirofiban versus tirofiban alone in Caucasian patients with acute anterior choroidal or paramedian pontine infarction. Brain Circ. 2024;10(3):250\u20136.","journal-title":"Brain Circ"},{"issue":"1","key":"1271_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12883-022-02808-w","volume":"22","author":"Z Liang","year":"2022","unstructured":"Liang Z, Zhang J, Huang S, Yang S, Xu L, Xiang W, et al. Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study. BMC Neurol. 2022;22(1):280.","journal-title":"BMC Neurol"},{"issue":"9","key":"1271_CR17","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1161\/STROKEAHA.113.001059","volume":"44","author":"AM Pancioli","year":"2013","unstructured":"Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, et al. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke. 2013;44(9):2381\u20137.","journal-title":"Stroke"},{"issue":"4","key":"1271_CR18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s11239-021-02584-3","volume":"53","author":"J Liu","year":"2022","unstructured":"Liu J, Yang Y, Liu H. Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies. J Thromb Thrombolysis. 2022;53(4):898\u2013910.","journal-title":"J Thromb Thrombolysis"},{"key":"1271_CR19","doi-asserted-by":"crossref","unstructured":"Tao C, Liu T, Cui T, Liu J, Li Z, Ren Y, et al. Early tirofiban infusion after intravenous thrombolysis for stroke. N Engl J Med. 2025.","DOI":"10.1056\/NEJMoa2503678"},{"issue":"9","key":"1271_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2314779","volume":"391","author":"O Adeoye","year":"2024","unstructured":"Adeoye O, Broderick J, Derdeyn CP, Grotta JC, Barsan W, Bentho O, et al. Adjunctive intravenous argatroban or eptifibatide for ischemic stroke. N Engl J Med. 2024;391(9):810\u201320.","journal-title":"N Engl J Med"},{"issue":"6","key":"1271_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.STR.30.6.1208","volume":"30","author":"TJ DeGraba","year":"1999","unstructured":"DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ. Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke. 1999;30(6):1208\u201312.","journal-title":"Stroke"},{"issue":"1-2","key":"1271_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000113732","volume":"25","author":"A Ois","year":"2008","unstructured":"Ois A, Martinez-Rodriguez JE, Munteis E, Gomis M, Rodriguez-Campello A, Jimenez-Conde J, et al. Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. 2008;25(1\u20132):151\u20136.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"1271_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.010","volume":"25","author":"JM Kim","year":"2016","unstructured":"Kim JM, Moon J, Ahn SW, Shin HW, Jung KH, Park KY. The etiologies of early neurological deterioration after thrombolysis and risk factors of ischemia progression. J Stroke Cerebrovasc Dis. 2016;25(2):383\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"1271_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJMra2000317","volume":"383","author":"R Vergallo","year":"2020","unstructured":"Vergallo R, Crea F. Atherosclerotic plaque healing. N Engl J Med. 2020;383(9):846\u201357.","journal-title":"N Engl J Med"},{"issue":"6","key":"1271_CR25","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1161\/STROKEAHA.110.580225","volume":"41","author":"WJ Kim","year":"2010","unstructured":"Kim WJ, Ko Y, Yang MH, Im SH, Park JH, Lee J, et al. Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism. Stroke. 2010;41(6):1200\u20134.","journal-title":"Stroke"},{"issue":"22","key":"1271_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037307","volume":"103","author":"J Sun","year":"2024","unstructured":"Sun J, Hao G, Song A, Xue Q. Effects of alteplase and aspirin on functional outcomes in patients with acute ischemic stroke and mild non-disabling neurological deficit. Medicine (Baltimore). 2024;103(22):e37307.","journal-title":"Medicine (Baltimore)"},{"key":"1271_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.785836","volume":"12","author":"B Han","year":"2021","unstructured":"Han B, Ma T, Liu Z, Wu Y, Tan W, Sun S, et al. Efficacy and safety of tirofiban in clinical patients with acute ischemic stroke. Front Neurol. 2021;12:785836.","journal-title":"Front Neurol"},{"key":"1271_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.982684","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang J, Ma Z, Mu G, Liang D, Li Y, et al. Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis. Front Neurol. 2022;13:982684.","journal-title":"Front Neurol"},{"issue":"4","key":"1271_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1747-4949.2012.00789.x","volume":"7","author":"A Del Bene","year":"2012","unstructured":"Del Bene A, Palumbo V, Lamassa M, Saia V, Piccardi B, Inzitari D. Progressive lacunar stroke: review of mechanisms, prognostic features, and putative treatments. Int J Stroke. 2012;7(4):321\u20139.","journal-title":"Int J Stroke"},{"issue":"5","key":"1271_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000235987","volume":"28","author":"J Philipps","year":"2009","unstructured":"Philipps J, Thomalla G, Glahn J, Schwarze M, Rother J. Treatment of progressive stroke with tirofiban--experience in 35 patients. Cerebrovasc Dis. 2009;28(5):435\u20138.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"1271_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/jamaneurol.2023.5093","volume":"81","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhong W, Xue R, Jin H, Gong X, Huang Y, et al. Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial. JAMA Neurol. 2024;81(2):118\u201325.","journal-title":"JAMA Neurol"},{"issue":"6","key":"1271_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaneurol.2024.0868","volume":"81","author":"W Zhao","year":"2024","unstructured":"Zhao W, Li S, Li C, Wu C, Wang J, Xing L, et al. Effects of tirofiban on neurological deterioration in patients with acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2024;81(6):594\u2013602.","journal-title":"JAMA Neurol"},{"issue":"10","key":"1271_CR33","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1161\/STROKEAHA.124.047688","volume":"55","author":"S Li","year":"2024","unstructured":"Li S, Wang L, Liu B, Zhang P, Zhang J, Chen G, et al. Clinical and prognostic characteristics of acute BAD-related stroke: a multicenter MRI-based prospective study. Stroke. 2024;55(10):2431\u20138.","journal-title":"Stroke"},{"issue":"1-2","key":"1271_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000442577","volume":"41","author":"L Petrone","year":"2016","unstructured":"Petrone L, Nannoni S, Del Bene A, Palumbo V, Inzitari D. Branch atheromatous disease: a clinically meaningful, yet unproven concept. Cerebrovasc Dis. 2016;41(1\u20132):87\u201395.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1271_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/bc.bc_54_23","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang Z, Hu Q, Liu L, Ma G, Yang C. Enhancing the clinical value of single-phase computed tomography angiography in the assessment of collateral circulation in acute ischemic stroke: a narrative review. Brain Circ. 2024;10(1):35\u201341.","journal-title":"Brain Circ"},{"issue":"3","key":"1271_CR36","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.STR.0000058480.77236.B3","volume":"34","author":"JM Wardlaw","year":"2003","unstructured":"Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34(3):806\u201312.","journal-title":"Stroke"},{"issue":"5","key":"1271_CR37","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1161\/01.STR.32.5.1154","volume":"32","author":"J Serena","year":"2001","unstructured":"Serena J, Leira R, Castillo J, Pumar JM, Castellanos M, Davalos A. Neurological deterioration in acute lacunar infarctions: the role of excitatory and inhibitory neurotransmitters. Stroke. 2001;32(5):1154\u201361.","journal-title":"Stroke"},{"key":"1271_CR38","doi-asserted-by":"crossref","unstructured":"Lee SH, Jang MU, Kim Y, Park SY, Kim C, Kim YJ, et al. Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment. J Clin Med. 2021;10(21).","DOI":"10.3390\/jcm10215147"},{"key":"1271_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620904131","volume":"26","author":"LS Zhou","year":"2020","unstructured":"Zhou LS, Li XQ, Zhou ZH, Chen HS. Effect of argatroban combined with dual antiplatelet therapy on early neurological deterioration in acute minor posterior circulation ischemic stroke. Clin Appl Thromb Hemost. 2020;26:1076029620904131.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1271_CR40","unstructured":"Chen HS, Cui Y, Li XQ, Wang XH, Jiang CH, Li J, et al. Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial. Eur Heart J. 2025."},{"issue":"5","key":"1271_CR41","first-page":"38","volume":"8","author":"AI Qureshi","year":"2016","unstructured":"Qureshi AI, Qureshi MH, Lobanova I, Bashir A, Khan AA, Bologna SM, et al. Histopathological characteristics of IV recombinant tissue plasminogen -resistant thrombi in patients with acute ischemic stroke. J Vasc Interv Neurol. 2016;8(5):38\u201345.","journal-title":"J Vasc Interv Neurol"},{"issue":"8","key":"1271_CR42","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00415-016-8181-5","volume":"263","author":"X Yi","year":"2016","unstructured":"Yi X, Wang C, Liu P, Fu C, Lin J, Chen Y. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol. 2016;263(8):1612\u20139.","journal-title":"J Neurol"},{"issue":"1","key":"1271_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/bc.bc_9_24","volume":"10","author":"A Elmadhoun","year":"2024","unstructured":"Elmadhoun A, Wang H, Ding Y. Impacts of futile reperfusion and reperfusion injury in acute ischemic stroke. Brain Circ. 2024;10(1):1\u20134.","journal-title":"Brain Circ"},{"issue":"27","key":"1271_CR44","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385(27):2520\u201330.","journal-title":"N Engl J Med"},{"issue":"28","key":"1271_CR45","doi-asserted-by":"publisher","first-page":"19900","DOI":"10.18632\/oncotarget.24945","volume":"9","author":"X Yi","year":"2018","unstructured":"Yi X, Lin J, Wang Y, Zhou J, Zhou Q, Wang C. Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke. Oncotarget. 2018;9(28):19900\u201310.","journal-title":"Oncotarget"},{"issue":"9","key":"1271_CR46","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00228-018-2468-7","volume":"74","author":"J Lin","year":"2018","unstructured":"Lin J, Han Z, Wang C, Yi X, Chai Z, Zhou Q, et al. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Eur J Clin Pharmacol. 2018;74(9):1131\u201340.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1271_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jth.13181","volume":"14","author":"JE Geddings","year":"2016","unstructured":"Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost. 2016;14(1):153\u201366.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1271_CR48","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20041497","volume":"201","author":"I Del Conde","year":"2005","unstructured":"Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005;201(6):871\u20139.","journal-title":"J Exp Med"},{"issue":"21","key":"1271_CR49","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1182\/bloodadvances.2020002923","volume":"4","author":"Y Suzuki","year":"2020","unstructured":"Suzuki Y, Sano H, Mochizuki L, Honkura N, Urano T. Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system. Blood Adv. 2020;4(21):5501\u201311.","journal-title":"Blood Adv"},{"issue":"4","key":"1271_CR50","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","volume":"28","author":"J Liu","year":"2019","unstructured":"Liu J, Shi Q, Sun Y, He J, Yang B, Zhang C, et al. Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(4):1126\u201332.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"1271_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071132","volume":"8","author":"S Amaro","year":"2013","unstructured":"Amaro S, Llull L, Urra X, Obach V, Cervera A, Chamorro A. Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke. PLoS ONE. 2013;8(8):e71132.","journal-title":"PLoS ONE"},{"issue":"10","key":"1271_CR52","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/STROKEAHA.116.014413","volume":"47","author":"W Li","year":"2016","unstructured":"Li W, Lin L, Zhang M, Wu Y, Liu C, Li X, et al. Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients. Stroke. 2016;47(10):2649\u201351.","journal-title":"Stroke"},{"issue":"10","key":"1271_CR53","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/WNL.0000000000003083","volume":"87","author":"HG Jeong","year":"2016","unstructured":"Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ, Lee SH. Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment. Neurology. 2016;87(10):996\u20131002.","journal-title":"Neurology"},{"issue":"12","key":"1271_CR54","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","volume":"50","author":"C Wu","year":"2019","unstructured":"Wu C, Sun C, Wang L, Lian Y, Xie N, Huang S, et al. Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis. Stroke. 2019;50(12):3481\u20137.","journal-title":"Stroke"},{"key":"1271_CR55","doi-asserted-by":"crossref","unstructured":"Krastev G, Mako M, Stevkova Z, Havranova R, Andrasikova K. Analysis of safety and efficacy of the early initiation of antithrombotic secondary prevention in patients treated with intravenous thrombolysis for acute ischemic stroke. J Clin Med. 2024;13(9).","DOI":"10.3390\/jcm13092710"},{"issue":"12","key":"1271_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106868","volume":"31","author":"DA Wells","year":"2022","unstructured":"Wells DA, Davis LK, Saeed O, Jones GM, Elangovan C, Alexandrov AV, et al. Safety of early antiplatelet administration in patients with acute ischemic stroke treated with alteplase (SEAPT-24). J Stroke Cerebrovasc Dis. 2022;31(12):106868.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"1271_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10072-024-07821-0","volume":"46","author":"H Kelani","year":"2025","unstructured":"Kelani H, Naeem A, Elhalag RH, Abuelazm M, Albaramony N, Abdelazeem A, et al. Early antiplatelet therapy after intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysis. Neurol Sci. 2025;46(2):617\u201331.","journal-title":"Neurol Sci"},{"issue":"5","key":"1271_CR58","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/17474930221118900","volume":"18","author":"XQ Li","year":"2023","unstructured":"Li XQ, Cui Y, Wang XH, Chen HS. Early antiplatelet for minor stroke following thrombolysis (EAST): rationale and design. Int J Stroke. 2023;18(5):615\u20139.","journal-title":"Int J Stroke"},{"issue":"6","key":"1271_CR59","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","volume":"48","author":"AD Barreto","year":"2017","unstructured":"Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, et al. Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke). Stroke. 2017;48(6):1608\u201316.","journal-title":"Stroke"},{"issue":"8","key":"1271_CR60","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.2023.0550","volume":"329","author":"HS Chen","year":"2023","unstructured":"Chen HS, Cui Y, Zhou ZH, Dai YJ, Li GH, Peng ZL, et al. Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS Randomized Clinical Trial. JAMA. 2023;329(8):640\u201350.","journal-title":"JAMA"},{"issue":"8","key":"1271_CR61","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archneur.63.8.1057","volume":"63","author":"RM Sugg","year":"2006","unstructured":"Sugg RM, Pary JK, Uchino K, Baraniuk S, Shaltoni HM, Gonzales NR, et al. Argatroban tPA stroke study: study design and results in the first treated cohort. Arch Neurol. 2006;63(8):1057\u201362.","journal-title":"Arch Neurol"},{"key":"1271_CR62","doi-asserted-by":"crossref","unstructured":"Chlorogiannis DD, Mavridis T, Adamou A, Kyriakoulis I, Stamatiou I, Botou P, et al. Argatroban as an Add-On to rtPA in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. J Clin Med. 2024;13(2).","DOI":"10.3390\/jcm13020563"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01271-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:02:22Z","timestamp":1773489742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-026-01271-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01271-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jing Wang, Sijie Li, Qingfeng Ma, Xunming Ji, Longfei Wu, and Wenbo Zhao declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Drs. Wenbo Zhao, Longfei Wu, and Sijie Li conceived the study. Dr. Jing Wang conducted the literature search and drafted the manuscript. Drs. Wenbo Zhao and Longfei Wu provided critical revisions. Drs. Qinfeng Ma and Xunming Ji contributed additional feedback during revisions. All authors reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}